TEAS Plus New Application

PTO- 1478

Approved for use through 02/28/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 02/28/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90545903

Filing Date: 02/25/2021

To the Commissioner for Trademarks:

MARK: Transplantation and Cellular Therapy (TCT) (Standard Characters, see mark)
The literal element of the mark consists of Transplantation and Cellular Therapy (TCT). The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, American Society for Transplantation and Cellular Therapy, a non-profit corporation legally organized under the laws of District of Columbia, having an address of
      330 North Wabash Avenue, Suite 2000
      Chicago, Illinois 60611
      United States
      312-321-6820(phone)
      312-673-6733(fax)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 009:  Downloadable journals in the field of medicine

Use in Commerce: The applicant is using the mark in commerce on or in connection with the identified goods/services. The applicant attaches, or will later submit, one specimen as a JPG/PDF image file showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, regardless of whether the mark itself is in the standard character format or is a stylized or design mark. The specimen image file may be in color, and the image must be in color if color is being claimed as a feature of the mark.

In International Class 009, the mark was first used by the applicant or the applicant's related company or licensee predecessor in interest at least as early as 01/01/2021, and first used in commerce at least as early as 01/01/2021, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) website page, pages from Journal.

Original PDF file:
SPE0-173165102129-2021022 4121433019802_._bsite_pag es_-_Transplantation_and_ Cellular_Therapy_-_Journa l.pdf
Converted PDF file(s) (4 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Original PDF file:
SPE0-173165102129-2021022 4121433019802_._Jan_2021_ Front_Matter.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3

Webpage URL: http://www.journals.elsevier.com/transplantation-and-cellular-therapy
Webpage Date of Access: 02/24/2021

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 016:  Printed publications, namely, journals in the field of medicine

Use in Commerce: The applicant is using the mark in commerce on or in connection with the identified goods/services. The applicant attaches, or will later submit, one specimen as a JPG/PDF image file showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, regardless of whether the mark itself is in the standard character format or is a stylized or design mark. The specimen image file may be in color, and the image must be in color if color is being claimed as a feature of the mark.

In International Class 016, the mark was first used by the applicant or the applicant's related company or licensee predecessor in interest at least as early as 01/01/2021, and first used in commerce at least as early as 01/01/2021, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) website pages, Journal pages.

Original PDF file:
SPE0-1-173165102129-20210 224121433019802_._bsite_p ages_-_Transplantation_an d_Cellular_Therapy_-_Jour nal.pdf
Converted PDF file(s) (4 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Original PDF file:
SPE0-1-173165102129-20210 224121433019802_._Jan_202 1_Front_Matter.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3

Webpage URL: http://www.journals.elsevier.com/transplantation-and-cellular-therapy
Webpage Date of Access: 02/24/2021



The owner's/holder's proposed attorney information: Kimberly A. Pendo. Other appointed attorneys are Jed R. Mandel. Recognized Canadian attorney(s)/agent(s) is/are Jed R. Mandel. Kimberly A. Pendo of Chicago Law Partners, LLC, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      333 W. Wacker Drive, Suite 810
      333 W. Wacker Drive, Suite 810
      Chicago, Illinois 60606
      United States
      312-929-1950(phone)
      312-929-1950(fax)
      kpendo@clpchicago.com
The docket/reference number is 013292.0701.
Kimberly A. Pendo submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Kimberly A. Pendo

PRIMARY EMAIL FOR CORRESPONDENCE: kpendo@clpchicago.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): ipdocket@clpchicago.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $500 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Andre Williams/   Date: 02/24/2021
Signatory's Name: Andre Williams
Signatory's Position: Executive Director
Signatory's Phone Number: 312-321-6820
Signature method: Sent to third party for signature
Payment Sale Number: 90545903
Payment Accounting Date: 02/25/2021

Serial Number: 90545903
Internet Transmission Date: Thu Feb 25 09:20:03 ET 2021
TEAS Stamp: USPTO/FTK-XXX.XXX.XXX.XXX-20210225092003
007730-90545903-77091435732dc9960caa16c5
7c980a8657dcf7d454191533b2270e2a96ad370-
CC-20010186-20210224172655355693